Global Next-generation Sequencing Market
On the Verge of a Quadrupled Competitor Size and a Clinical Turning Point
LONDON, Jan. 5, 2015 /PRNewswire/ -- The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research service offers a discussion of the key market drivers and restraints, revenue forecasts by region (United States, Western Europe, and Asia-Pacific/Rest of World) and product types, as well as important trends affecting growth. This analysis also presents key companies to watch, major market dynamics, and strategic recommendations for competitors.
Methodology
The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with next-generation sequencing instrument and reagent providers. Most consultations were conducted with vice presidents (VPs) of business units, VPs of marketing, product managers, marketing managers, marketing directors, and business development directors from various competitors in the next-generation sequencing market. Industry-specific information obtained includes:
-Next-generation sequencing revenue breakdowns by technology segments and regions
-Company revenues, market share estimates, and projected growth rates of various competitors
-Top-level customer, regional, and technology market trend information
-Market drivers, restraints, and challenges Supplementary research was conducted utilizing secondary sources including scientific journals, online media, Frost & Sullivan databases and research services, and publicly available corporate filings. Forecasts are based on the data and analyses regarding industry challenges, market drivers and restraints, and market trends. If specific revenues or market sizes were unavailable, estimates were derived through the consultations with industry experts, augmented by secondary research. Growth trends specific to certain market participants are based on consultations, past growth rates, and technology reviews.
Key Findings
-The global market for next-generation sequencing (NGS), including instruments and reagents, generated revenue of $million in 2013; it is expected to reach $ million in 2018. The market is expected to grow at a CAGR of % from 2013 to 2018.
-The global NGS instruments market generated $ million in 2013; a CAGR of % is expected from 2013 to 2018. The global reagents market totaled $ million in 2013 and is expected to grow at a CAGR of % through 2018.
-The NGS instruments and reagents markets combined in the United States contributed % of the global revenue in 2013. Western Europe generated % of global revenue, and Asia-Pacific and Rest of World (APAC/ROW) generated %.
-Key vendors in the NGS instruments space include Illumina, Life Technologies, Pacific Biosciences, and Roche (until the company exits the market in 2015). Emerging competitors expected to enter the NGS instruments market include Oxford Nanopore, GnuBIO (acquired by Bio-Rad in 2014), Qiagen (Intelligent Bio-Systems), GenapSys, DNA Electronics, NabSys, Genia Technologies, and Noblegen Biosciences.
-Key vendors in the NGS reagents market include Illumina, Life Technologies, Roche, Agilent, Qiagen, and New England Biolabs. This competitor base includes a number of smaller participants, and is expected to expand as companies develop NGS products to take advantage of strong market growth.
-The use of sequencing in clinical applications is the most significant driver of the global market, yet it will take to years to generate revenue nearing the well-established research market.
-The $ genome (not including bioinformatics or data analysis) has been reached with Illumina's launch of the X Ten system. This launch will drive whole human genome sequencing and the development of large databases to better extract the clinical utility of the genome.
Download the full report: https://www.reportbuyer.com/product/2200858/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-next-generation-sequencing-market-300015071.html
SOURCE ReportBuyer
Share this article